title: Retroviral vectors designed for targeted expression of RNA polymerase III-driven transcripts: a comparative study.
abstract: Retroviral gene delivery systems for RNA polymerase II (RNA pol II)-based promoters have been developed and are widely used in gene transfer studies. In contrast, gene delivery systems with RNA pol III-based expression cassettes have not been studied comprehensively, although therapeutic applications (e.g., ribozymes, antisense, triplex RNA and RNA decoys) have been proposed. In this report, we describe retroviral vectors designed to optimize expression of short chimeric RNAs transcribed from a number of RNA pol III promoters. Our results show that all analysed RNA pol III expression cassettes (tRNA, U6, Ad VA1), regardless of orientation, do not transcribe efficiently when located between the retroviral long terminal repeats (LTRs). In contrast, high steady-state expression levels can be achieved by inserting the RNA pol III expression cassette into the U3 region of the LTR (double-copy design). Compared to human tRNA gene promoters (tRNA(Met), tRNA(Val)), the human small nuclear RNA U6 gene (U6) and the adenovirus virus-associated RNA 1 (Ad VA1) gene promoters yielded higher expression levels. The majority of the chimeric U6-derived transcripts were detected in the nuclear RNA fraction, and the VA1 and tRNA-driven transcripts were predominantly detected in the cytoplasmic compartments. This report is the first comparative study of RNA pol III-driven promoters expressing short chimeric transcripts leading to an optimized retroviral-vector design.
authors.affiliation: Systemix Inc., Department of Molecular Therapy, Palo Alto, CA 94304, USA.
authors.forename: H
authors.initials: H
authors.lastname: Ilves
authors.forename: C
authors.initials: C
authors.lastname: Barske
authors.forename: U
authors.initials: U
authors.lastname: Junker
authors.forename: E
authors.initials: E
authors.lastname: Böhnlein
authors.forename: G
authors.initials: G
authors.lastname: Veres
mesh_terms: D000256:Adenoviridae / Q000235:genetics; D000818:Animals; D002460:Cell Line; D015694:Gene Products, rev / Q000235:genetics; D005822:Genetic Vectors / Q000737:chemistry / Q000235:genetics*; D006678:HIV / Q000235:genetics; D006367:HeLa Cells; D006801:Humans; D051379:Mice; D011401:Promoter Regions, Genetic; D012320:RNA Polymerase III / Q000096:biosynthesis / Q000235:genetics*; D016337:RNA, Catalytic / Q000235:genetics; D012358:RNA, Transfer, Met / Q000235:genetics; D012366:RNA, Transfer, Val / Q000235:genetics; D012367:RNA, Viral; D011994:Recombinant Proteins / Q000235:genetics; D012190:Retroviridae / Q000235:genetics*; D017414:Ribonucleoprotein, U4-U6 Small Nuclear / Q000235:genetics; D013347:Subcellular Fractions; D014158:Transcription, Genetic; D015533:Transcriptional Activation; D014161:Transduction, Genetic; D054321:rev Gene Products, Human Immunodeficiency Virus
chemical_list: D015694:Gene Products, rev; D016337:RNA, Catalytic; D012358:RNA, Transfer, Met; D012366:RNA, Transfer, Val; D012367:RNA, Viral; D011994:Recombinant Proteins; D017414:Ribonucleoprotein, U4-U6 Small Nuclear; D054321:rev Gene Products, Human Immunodeficiency Virus; D012320:RNA Polymerase III